Literature DB >> 12215339

Retinoids and steroids regulate menstrual phase histological features in human endometrial organotypic cultures.

Scott Kamelle1, Anna Sienko, Doris M Benbrook.   

Abstract

OBJECTIVE: To determine whether organotypic cultures of human endometrium can be manipulated with hormones to exhibit histological features resembling different menstrual cycle phases.
DESIGN: Human menstrual cells were collected and cultured in monolayer and organotypic cultures.
SETTING: Healthy volunteer in an academic research environment. PATIENT(S): An individual premenopausal woman. INTERVENTION(S): Endometrial cultures were grown in collagen gels for 4 weeks, and exposed to various steroid and retinoid treatments. MAIN OUTCOME MEASURE(S): Histological features and expression of cytokeratins, vimentin, and reticulin. RESULT(S): Cultures developed multiple glands and surface epithelium that exhibited positive cytokeratin and negative vimentin staining. Single stromal cells inside the collagen exhibited negative cytokeratin and positive vimentin staining. Networks of reticulin fibers produced by the cells were increased by estrogen, decreased by progesterone, and unaffected by retinoids. Contraction of the collagen gels was inhibited by retinoids that activated retinoic acid receptors (RARs), but not by a retinoid specific for retinoid X receptors (RXRs). The combination and timing of retinoid and steroid hormone treatments were demonstrated to induce tissue architecture and histological features that resembled either proliferative or secretory phases. CONCLUSION(S): Growth of menstrual cells in collagen can be manipulated with retinoids and steroids to resemble histological features of the proliferative and secretory phases.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12215339     DOI: 10.1016/s0015-0282(02)03302-2

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  10 in total

1.  A tissue-engineered human endometrial stroma that responds to cues for secretory differentiation, decidualization, and menstruation.

Authors:  Stacey C Schutte; Robert N Taylor
Journal:  Fertil Steril       Date:  2012-02-10       Impact factor: 7.329

2.  Inhibition of BMI1, a Therapeutic Approach in Endometrial Cancer.

Authors:  Megan Buechel; Anindya Dey; Shailendra Kumar Dhar Dwivedi; Aleia Crim; Kai Ding; Roy Zhang; Priyabrata Mukherjee; Kathleen N Moore; Liangxian Cao; Arthur Branstrom; Marla Weetall; John Baird; Resham Bhattacharya
Journal:  Mol Cancer Ther       Date:  2018-07-19       Impact factor: 6.261

3.  Flex-Hets differentially induce apoptosis in cancer over normal cells by directly targeting mitochondria.

Authors:  Tongzu Liu; Bethany Hannafon; Lance Gill; William Kelly; Doris Benbrook
Journal:  Mol Cancer Ther       Date:  2007-06       Impact factor: 6.261

4.  Heteroarotinoids with anti-cancer activity against ovarian cancer cells.

Authors:  Thanh C Le; K Darrell Berlin; Stacy D Benson; Margaret A Eastman; Gianna Bell-Eunice; Anna C Nelson; Doris M Benbrook
Journal:  Open Med Chem J       Date:  2007-10-24

5.  Sensitivities of Uterine Adenocarcinoma, Mixed Mullerian Tumor (MMT) and Sarcoma Cell Lines to Chemotherapeutic Agents and a Flex-Het Drug.

Authors:  Johnny Hyde; Doris M Benbrook
Journal:  Am J Pharmacol Toxicol       Date:  2006-01-01

6.  Effect of all-trans retinoic acid on tissue dynamics of choriocarcinoma cell lines: an organotypic model.

Authors:  P M Chiu; H C Feng; D M Benbrook; H Y S Ngan; U S Khoo; W C Xue; S W Tsao; K W Chan; A N Y Cheung
Journal:  J Clin Pathol       Date:  2006-02-06       Impact factor: 3.411

7.  Selective growth inhibition of cancer cells by L-methioninase-containing fusion protein targeted to the urokinase receptor.

Authors:  Naveen R Palwai; Xiao-Ping Zang; Roger G Harrison; Doris Benbrook; J Thomas Pento
Journal:  Pharmacology       Date:  2009-10-01       Impact factor: 2.547

8.  Induction of death receptor ligand-mediated apoptosis in epithelial ovarian carcinoma: The search for sensitizing agents.

Authors:  Katherine Marie Moxley; Shylet Chengedza; Doris Mangiaracina Benbrook
Journal:  Gynecol Oncol       Date:  2009-10-04       Impact factor: 5.482

9.  Gene expression analysis of biological systems driving an organotypic model of endometrial carcinogenesis and chemoprevention.

Authors:  Doris M Benbrook; Stan Lightfoot; James Ranger-Moore; Tongzu Liu; Shylet Chengedza; William L Berry; Igor Dozmorov
Journal:  Gene Regul Syst Bio       Date:  2008

10.  p21-Activated Kinases 1, 2 and 4 in Endometrial Cancers: Effects on Clinical Outcomes and Cell Proliferation.

Authors:  Michelle K Y Siu; Daniel S H Kong; Sheila Y P Ngai; Hoi Yan Chan; Lili Jiang; Esther S Y Wong; Stephanie S Liu; Karen K L Chan; Hextan Y S Ngan; Annie N Y Cheung
Journal:  PLoS One       Date:  2015-07-28       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.